CFDE Data Portal | Search LINC01587

	Label	Description
	LINC01587 Gene (Entity type)	ENSG00000082929 - long intergenic non-protein coding RNA 1587
	GSE139178 GDC-0068 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE110709 GSK-J4 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE240741 L-13 TIME 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203522 dopamine SH-SY5Y 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203522 dopamine SH-SY5Y 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE227071 GSE246680 dopamine neuron 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE189859 GSE189861 IDH1 knockout 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE138863 disulfiram 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC01587

ENSG00000082929 - long intergenic non-protein coding RNA 1587

GSE139178 GDC-0068 3 v 1 human dn

A Gene Set from LINCS

GSE110709 GSK-J4 5 v 4 human dn

A Gene Set from LINCS

GSE240741 L-13 TIME 4 v 6 human dn

A Gene Set from LINCS

GSE172494 nicotinamide 3 v 1 human dn

A Gene Set from LINCS

GSE203522 dopamine SH-SY5Y 2 v 3 human dn

A Gene Set from LINCS

GSE203522 dopamine SH-SY5Y 2 v 1 human dn

A Gene Set from LINCS

GSE227071 GSE246680 dopamine neuron 0 v 1 human up

A Gene Set from LINCS

GSE189859 GSE189861 IDH1 knockout 4 v 2 human up

A Gene Set from LINCS

GSE138863 disulfiram 2 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.